Both peptides appear well tolerated in the limited settings studied, but long-term systemic human safety is uncharacterized for each, and research-grade material carries unverified identity and purity
The BPC-157 TB-500 nasal spray represents a breakthrough in peptide delivery that's transforming how health fitness coaches, medispa professionals, and peptide enthusiasts approach recovery, healing, and performance optimization
[8] Novo Nordisk announced late at the 2025 European Association for the Study of Diabetes (EASD) annual meeting that in the REDEFINE 1 study, [9] cagrilintide provided clinically significant weight loss, with a mean reduction in body weight of 11.8% compared to 2.3% with placebo after 68 weeks, considering adherence of all participants to treatment
Refyne and Defyne are each $750 per syringe, with most patients using 1 or 2 syringes of these for their chin
J Clin Invest Chavoshinezhad S et al (2021) Optogenetic stimulation of entorhinal cortex reveals the implication of insulin signaling in adult rats hippocampal neurogenesis